Healthcare >> CEO Interviews >> May 8, 2002
JULIA L. GREENSTEIN is currently the Chief Executive Officer and
President at Immerge BioTherapeutics, Inc. Dr. Greenstein
received her PhD in Microbiology from the University of Rochester
Medical School based on work in the laboratory of Dr. Philippa
Marrack. She did postdoctoral training at both the University of
Rochester Medical School and the Dana Farber Cancer Institute of
Harvard Medical School. Dr. Greenstein joined the faculty of
Harvard Medical School and was appointed an Assistant Professor.
Dr. Greenstein was Vice President of Discovery Research and among
the founding scientists at Immulogic Pharmaceutical Corporation,
working on allergen derived peptide induced tolerance for the
treatment of allergic disease and on haptenized peptide
conjugates for the treatment of cocaine addiction. Profile
Dr. Greenstein: Immerge BioTherapeutics is a joint venture
between Novartis Pharma and BioTransplant, Inc., and the joint
venture was
